Product Details
Cervarix Vaccine## (check composition)
Human papillomavirus bivalent (types 16 & 18) vaccine0.5 mL
Suspension
ROA
Intramuscular
Applicant Name
Glaxo Smithkline Consumer Nigeria PLC
NRN
A6-0012
Status
Active
Composition
Each dose (0.5 mL) contains: Human Papillomavirus Type 16 L1 protein 20 mcg, , Human Papillomavirus Type 18 L1 protein 20 mcg, 3-O-desacyl-4' - Monophosphoryl Lipid A (MPL) 50 mcg, Aluminium Hydroxide, hydrated 0.5 mg Al3+ Excipients q.s.
ATC Code
J07BM02
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 0.5 mL (in pre-filled syringe/vial)
Product Description
Suspension for Injection HUMAN PAPILLOMAVIRUS VACCINE TYPES 16 AND 18 0.5ml N/A Turbid white suspension in a pre-filled syringe + 1 needle SUSPENSION GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD. GlaxoSmithKline Biologicals S.A., 89, Rue de l'Institut, 1330 Rixensart, Belgium 03/12/2023 29/11/2028
Manufacturer Name
Glaxosmithkline Biologicals S.A
Manufacturer Country
BELGIUM
Approval Date
2023-11-30
Expiry Date
2028-11-29